Trade Summary

Yesterday, DUGGAN ROBERT W, serving as Co-Chief Executive Officer at Summit Therapeutics Inc. (SMMT), purchased 100,000 shares at $14.60 per share, for a total transaction value of $1,460,000.00. Following this transaction, DUGGAN ROBERT W now holds 25,824,474 shares of SMMT.

This purchase represents a 0.39% increase in DUGGAN ROBERT W's stake in the company.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 at 6:08 PM ET, meaning the disclosure happened on the same day as the trade.

Summit Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.